| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.008 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.009 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |